# LATISSE
> **NDA022369** · New Drug Application · Sponsor: ABBVIE · Approved 2008-12-24
## Drug
- **FDA Application Number:** NDA022369
- **Application type:** New Drug Application
- **Brand name:** LATISSE
- **Generic name:** BIMATOPROST
- **Active ingredients:** BIMATOPROST
- **Dosage form:** SOLUTION/DROPS
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2008-12-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022369)
---
*MORVS · CC0 1.0*